Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
prednisolondråber |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prednisolone ophthalmic preparation |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prednisolone |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing prednisolone (medicinal product) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing neomycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antiinfektiøst middel til huden |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin (substance) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
binyrehormonmiddel |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
glucocorticoidhormon |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing neomycin and prednisolone (medicinal product) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin sulfate |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prednisolone sodium phosphate |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Has manufactured dose form |
Ear and eye drops |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Has concentration strength denominator value |
en |
false |
Inferred relationship |
Some |
1 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Has concentration strength numerator value |
fem |
false |
Inferred relationship |
Some |
1 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Neomycin sulfate |
false |
Inferred relationship |
Some |
1 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
This attribute specifies the denominator unit for the concentration strength of a product. |
mL |
false |
Inferred relationship |
Some |
1 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Neomycin sulfate |
false |
Inferred relationship |
Some |
1 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Has concentration strength numerator value |
fem |
false |
Inferred relationship |
Some |
2 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
This attribute specifies the denominator unit for the concentration strength of a product. |
mL |
false |
Inferred relationship |
Some |
2 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Prednisolone sodium phosphate |
false |
Inferred relationship |
Some |
2 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Has concentration strength denominator value |
en |
false |
Inferred relationship |
Some |
2 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
false |
Inferred relationship |
Some |
1 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Prednisolone sodium phosphate |
false |
Inferred relationship |
Some |
2 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Count of base of active ingredient |
to |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Has manufactured dose form |
Conventional release solution for ear and eye drops (dose form) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
false |
Inferred relationship |
Some |
2 |
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing neomycin in ophthalmic dosage form |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing neomycin in otic dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing prednisolone in ocular dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing neomycin in ocular dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing only neomycin and prednisolone (medicinal product) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Neomycin and prednisolone only product in ocular dose form |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Is a |
Product containing only neomycin and prednisolone in otic dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|